Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00925223|
Recruitment Status : Unknown
Verified October 2009 by Shandong University.
Recruitment status was: Enrolling by invitation
First Posted : June 22, 2009
Last Update Posted : October 14, 2009
|Condition or disease|
|Irritable Bowel Syndrome|
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Observational Model:||Case Control|
|Official Title:||Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients|
|Study Start Date :||June 2009|
|Estimated Primary Completion Date :||August 2009|
|Estimated Study Completion Date :||November 2009|
irritable bowel syndrome
patients with diarrhea-predominant IBS will be enrolled in this group.
patients with colon cancer or colon polyp will be enrolled as control group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00925223
|Study Director:||Yanqing Li, PhD. MD.||Department of Gastroenterology, Qilu Hospital, Shandong University|